Inherited Retinal Diseases (IRDs) form a complex array of genetic disorders impacting the retina, gradually diminishing vision. Conditions like retinitis pigmentosa, Leber congenital amaurosis, and Stargardt disease arise from genetic mutations, often surfacing in childhood or early adulthood and presenting with varying severity and progression. These diseases stem from genetic anomalies disrupting vital retinal functions, such as phototransduction or retinal development. Symptoms include night blindness, peripheral vision loss, and, in later stages, central vision impairment. Though currently lacking a cure, ongoing research into gene therapy, stem cell therapy, and retinal prosthetics sparks optimism for future treatments. Timely genetic testing aids in tailored management plans and facilitates participation in clinical trials, offering a glimmer of hope for enhanced outcomes in the management of these intricate conditions.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom